Products for Research Use Only
RegisterLogin

PARG-IN-6

CAT: 0931-T210766-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T210766-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
3083070-66-7
Target
Poly (ADP-ribose) Glycohydrolase (PARG)
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
PARG-IN-6 (Compound 2) is an orally bioavailable PARG inhibitor with an IC50 of 0.3 nM. It exhibits significant anticancer activity against cancer cells, with an IC50 of 0.0368 μM for HCC1395 cells. PARG-IN-6 shows potential for research in colon cancer, appendiceal cancer, and pancreatic cancer.
Smiles
N#CC1(NS(=O)(=O)C2=CC=3C(=NN(C3C(=C2F)C4=C(C)CN(CC4)S(=O)(=O)C(C)C)C)C5=NN=C(S5)C(F)(F)F)CC1
Molecular Formula
C24H25F4N7O4S3
Molecular Weight
647.69
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T81546-01PARG-IN-4
T212151-01PARG-IN-7
T200198-01PAR4 antagonist 6
TP3479-01PAR3 (1-6) (human)
T36293PAR 4 (1-6)
T36531-01PAR2 (1-6) (mouse, rat)
TP3198-01PAR-4 (1-6), mouse
T76650PAR-2 (1-6) (human)
T75904-01PAR 4 (1-6) (TFA)
TP2612-01PAR-4 (1-6) amide (human)

Alternative Products

CatalogName
GTR19263276-01PARG-IN-6
BLG-N051-016-Parg-NAD+
MBS8535413-01PARG
HY-156881-01PARG-IN-4
571466-01PARG (FITC)
OACA10603-100UGPARG Antibody
TS408530P5PARG CytoSection
HY-171789PARG-IN-7
DF13517-BPPARG Peptide
B2022080PARG (Human)

Popular Products